Scholar Rock Holding Corporation
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Scholar Rock Holding Corporation
Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions.
/ 
Frequently asked questions
To buy Scholar Rock Holding Corporation stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Scholar Rock Holding Corporation by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Scholar Rock Holding Corporation is SRRK:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Scholar Rock Holding Corporation has its primary listing on NASDAQ. You can trade Scholar Rock Holding Corporation with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Scholar Rock Holding Corporation is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Scholar Rock Holding Corporation as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Scholar Rock Holding Corporation.